Richard Vosser
Stock Analyst at J.P. Morgan
(3.00)
# 2,529
Out of 4,339 analysts
1197
Total ratings
48.3%
Success rate
1.4%
Average return
Main Sectors:
Stocks Rated by Richard Vosser
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ETR: MRK Merck KGaA | Maintained: Buy | €150.00 | $128.35 | +16.87% | 144 | May 26, 2026 | |
| LON: AZN AstraZeneca PLC | Maintained: Buy | 16,000p | $13,960.00 | +14.61% | 28 | May 14, 2026 | |
| ETR: BAYN Bayer Aktiengesellschaft | Maintained: Buy | €50.00 | $37.82 | +32.21% | 142 | May 12, 2026 | |
| LON: 0QIU Novo Nordisk A/S | Maintained: Hold | kr 250.00 | $288.35 | -13.30% | 153 | May 6, 2026 | |
| SWX: NOVN Novartis AG | Maintained: Buy | CHF 135.00 | $118.44 | +13.98% | 118 | May 5, 2026 | |
| EPA: SAN Sanofi | Maintained: Hold | €95.00 | $76.32 | +24.48% | 162 | May 5, 2026 | |
| SWX: ROP Roche Holding AG | Maintained: Hold | CHF 325.00 | $331.20 | -1.87% | 191 | May 1, 2026 | |
| ETR: SRT3 Sartorius Aktiengesellschaft | Maintained: Buy | €295.00 | $233.00 | +26.61% | 73 | Apr 23, 2026 | |
| EPA: DIM Sartorius Stedim Biotech S.A. | Maintained: Buy | €260.00 | $171.70 | +51.43% | 27 | Apr 23, 2026 | |
| EPA: IPN Ipsen S.A. | Maintained: Hold | €130.00 | $161.40 | -19.45% | 15 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €950.00 | $699.70 | +35.77% | 3 | Mar 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $1,925.00 | - | 7 | Dec 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $925 → $1,100 | $808.43 | +36.07% | 2 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €230.00 → €300.00 | $243.60 | +23.15% | 19 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 3.50 → CHF 3.00 | $3.08 | -2.60% | 15 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $44.19 | - | 21 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $150.80 | - | 4 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4.5 → $4 | $4.05 | -1.23% | 8 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €250.00 → €260.00 | $182.60 | +42.39% | 17 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 645.00 → CHF 650.00 | $491.50 | n/a | 15 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €3.00 → €3.50 | $1.46 | n/a | 6 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $55 → $40 | $10.92 | n/a | 7 | Dec 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | €42.96 | $51.30 | n/a | 1 | Jan 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 3,000p | $1,480.00 | n/a | 7 | Sep 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $176 | $44.94 | n/a | 1 | Mar 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $52.60 | n/a | 3 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $144 | $142.12 | n/a | 1 | Jul 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $205 → $200 | $27.64 | n/a | 2 | Mar 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €185.00 | $23.84 | n/a | 1 | Jan 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | kr 1,150 | $1,723.63 | n/a | 1 | Jan 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $26.89 | n/a | 1 | Jan 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $44.15 | n/a | 1 | Apr 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $22 | $8.01 | n/a | 1 | Jan 4, 2017 |
Merck KGaA
May 26, 2026
Maintained: Buy
Price Target: €150.00
Current: $128.35
Upside: +16.87%
AstraZeneca PLC
May 14, 2026
Maintained: Buy
Price Target: 16,000p
Current: $13,960.00
Upside: +14.61%
Bayer Aktiengesellschaft
May 12, 2026
Maintained: Buy
Price Target: €50.00
Current: $37.82
Upside: +32.21%
Novo Nordisk A/S
May 6, 2026
Maintained: Hold
Price Target: kr 250.00
Current: $288.35
Upside: -13.30%
Novartis AG
May 5, 2026
Maintained: Buy
Price Target: CHF 135.00
Current: $118.44
Upside: +13.98%
Sanofi
May 5, 2026
Maintained: Hold
Price Target: €95.00
Current: $76.32
Upside: +24.48%
Roche Holding AG
May 1, 2026
Maintained: Hold
Price Target: CHF 325.00
Current: $331.20
Upside: -1.87%
Sartorius Aktiengesellschaft
Apr 23, 2026
Maintained: Buy
Price Target: €295.00
Current: $233.00
Upside: +26.61%
Sartorius Stedim Biotech S.A.
Apr 23, 2026
Maintained: Buy
Price Target: €260.00
Current: $171.70
Upside: +51.43%
Ipsen S.A.
Mar 27, 2026
Maintained: Hold
Price Target: €130.00
Current: $161.40
Upside: -19.45%
Mar 5, 2026
Maintained: Buy
Price Target: €950.00
Current: $699.70
Upside: +35.77%
Dec 23, 2025
Maintained: Sell
Price Target: n/a
Current: $1,925.00
Upside: -
Dec 8, 2025
Maintained: Buy
Price Target: $925 → $1,100
Current: $808.43
Upside: +36.07%
Dec 8, 2025
Maintained: Buy
Price Target: €230.00 → €300.00
Current: $243.60
Upside: +23.15%
Dec 8, 2025
Maintained: Hold
Price Target: CHF 3.50 → CHF 3.00
Current: $3.08
Upside: -2.60%
Nov 24, 2025
Maintained: Buy
Price Target: n/a
Current: $44.19
Upside: -
Nov 20, 2025
Maintained: Hold
Price Target: n/a
Current: $150.80
Upside: -
Sep 3, 2025
Maintained: Hold
Price Target: $4.5 → $4
Current: $4.05
Upside: -1.23%
Jul 22, 2025
Maintained: Buy
Price Target: €250.00 → €260.00
Current: $182.60
Upside: +42.39%
Dec 3, 2024
Maintained: Buy
Price Target: CHF 645.00 → CHF 650.00
Current: $491.50
Upside: n/a
Dec 3, 2024
Maintained: Hold
Price Target: €3.00 → €3.50
Current: $1.46
Upside: n/a
Dec 5, 2023
Maintained: Hold
Price Target: $55 → $40
Current: $10.92
Upside: n/a
Jan 3, 2023
Upgraded: Buy
Price Target: €42.96
Current: $51.30
Upside: n/a
Sep 27, 2021
Maintained: Buy
Price Target: 3,000p
Current: $1,480.00
Upside: n/a
Mar 18, 2021
Maintained: Buy
Price Target: $176
Current: $44.94
Upside: n/a
Dec 21, 2020
Maintained: Buy
Price Target: n/a
Current: $52.60
Upside: n/a
Jul 28, 2020
Maintained: Buy
Price Target: $144
Current: $142.12
Upside: n/a
Mar 2, 2020
Maintained: Hold
Price Target: $205 → $200
Current: $27.64
Upside: n/a
Jan 6, 2020
Downgraded: Hold
Price Target: €185.00
Current: $23.84
Upside: n/a
Jan 2, 2019
Downgraded: Hold
Price Target: kr 1,150
Current: $1,723.63
Upside: n/a
Jan 2, 2019
Downgraded: Hold
Price Target: n/a
Current: $26.89
Upside: n/a
Apr 11, 2017
Upgraded: Hold
Price Target: n/a
Current: $44.15
Upside: n/a
Jan 4, 2017
Upgraded: Buy
Price Target: $22
Current: $8.01
Upside: n/a